Source: High Tide Inc.
  • High Tide (HITI) has opened its third Canna Cabana retail cannabis store in Vancouver
  • This opening marks High Tide’s 141st Canna Cabana branded retail cannabis location in Canada
  • High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets
  • High Tide Inc. (HITI) is up 4.37 per cent, trading at C$1.91 per share at 12:42 pm ET

High Tide (HITI) has opened its third Canna Cabana retail cannabis store in Vancouver.

The store will begin selling recreational cannabis products and consumption accessories for adult use today at 4:20 PM. This opening marks High Tide’s 141st Canna Cabana branded retail cannabis location in Canada. It is the fourth store in British Columbia and the third in Vancouver.

This is the first Canna Cabana location in Dunbar Village, Vancouver. It is located around the corner from a major national grocery chain and a popular Vancouver liquor store. It is also a short drive from both the University of British Columbia and Langara College, which collectively have a student population of over 80,000.

Raj Grover, President and CEO of High Tide, commented on the announcement.

“I am pleased to announce the opening of our third Canna Cabana location in Vancouver, which is the epicentre of world-famous BC bud. Vancouver is an important market to expand our Canna Cabana brand. This is due to its large population, popularity with tourists and favourable municipal distance requirements between Cannabis stores. It yields greater returns over other markets.”

High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets.

High Tide Inc. (HITI) is up 4.37 per cent, trading at C$1.91 per share at 12:42 pm ET.


More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.